Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner

Publisher： John Wiley & Sons Inc

E-ISSN： 1878-0261|12|2|180-195

ISSN： 1574-7891

Source： Molecular Oncology, Vol.12, Iss.2, 2018-02, pp. : 180-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 2, 2015-02 ,pp. : 155-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autophagy inhibition enhances isobavachalcone-induced cell death in multiple myeloma cells

By              

International Journal of Molecular Medicine, Vol. 30, Iss. 4, 2012-01 ,pp. : 939-944

Spandidos Publications

Access to resources Recommend Favorite

Romidepsin Overcomes Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma Cells

By  

Acta Haematologica, Vol. 132, Iss. 1, 2013-12 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Combining BRAFV600E inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 9, 2015-09 ,pp. : 709-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression

By                

International Journal of Molecular Medicine, Vol. 33, Iss. 1, 2014-01 ,pp. : 91-96

Spandidos Publications

Access to resources Recommend Favorite